Bath & Body Works, Inc. (NYSE:BBWI) Receives $43.06 Average PT from Analysts

Bath & Body Works, Inc. (NYSE:BBWI) has earned a consensus recommendation of “Moderate Buy” from the seventeen brokerages that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and ten have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $43.06.

A number of equities analysts recently weighed in on the company. Telsey Advisory Group reissued an “outperform” rating and issued a $42.00 price target on shares of Bath & Body Works in a research note on Monday, November 25th. Barclays lifted their target price on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 26th. Morgan Stanley reduced their price target on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. Piper Sandler lifted their price objective on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th.

Bath & Body Works Price Performance

BBWI stock opened at $36.78 on Monday. The firm has a market cap of $7.97 billion, a PE ratio of 8.97, a P/E/G ratio of 0.98 and a beta of 1.82. Bath & Body Works has a 12 month low of $26.20 and a 12 month high of $52.99. The firm has a 50 day simple moving average of $36.30 and a 200 day simple moving average of $33.68.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.03. The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company’s revenue was up 3.1% compared to the same quarter last year. During the same period last year, the company posted $0.48 EPS. As a group, sell-side analysts expect that Bath & Body Works will post 3.26 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were issued a $0.20 dividend. The ex-dividend date of this dividend was Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.18%. Bath & Body Works’s dividend payout ratio is currently 19.51%.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of BBWI. Anomaly Capital Management LP bought a new position in shares of Bath & Body Works in the 2nd quarter valued at approximately $113,995,000. FMR LLC grew its holdings in Bath & Body Works by 17,496.5% during the third quarter. FMR LLC now owns 2,516,127 shares of the company’s stock valued at $80,315,000 after purchasing an additional 2,501,828 shares during the last quarter. KBC Group NV raised its position in shares of Bath & Body Works by 9,023.5% in the third quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock valued at $54,322,000 after purchasing an additional 1,683,160 shares during the period. Erste Asset Management GmbH bought a new position in shares of Bath & Body Works in the third quarter valued at approximately $50,483,000. Finally, Lone Pine Capital LLC lifted its stake in shares of Bath & Body Works by 15.8% in the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock worth $441,871,000 after buying an additional 1,547,399 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.